Immunocore is an England-based biotechnology company that develops and commercializes biological therapies for the treatment of cancer.Read more
Gritstone Oncology is a top competitor of Immunocore. Gritstone Oncology was founded in 2015, and is headquartered in Emeryville, California. Like Immunocore, Gritstone Oncology also competes in the Biotechnology field. Gritstone Oncology generates $3.9M more revenue vs. Immunocore.
Adaptimmune is seen as one of Immunocore's top competitors. Adaptimmune is headquartered in Oxfordshire, England, and was founded in 2008. Like Immunocore, Adaptimmune also operates in the Biotechnology field. Adaptimmune generates 15% the revenue of Immunocore.
Today 5:16 PM
September 27, 2021
Immunocore's revenue is the ranked 9th among it's top 10 competitors. The top 10 competitors average 5B. Over the last two quarters, Immunocore's revenue has decreased by 0%. Specifically, in Q4 2020's revenue was $40.9M; in Q3 2020, it was $40.9M.
No recent acquisitions found related to Immunocore
Since Immunocore was founded in 2008, it has participated in 6 rounds of funding. In total Immunocore has raised $923.3M. Immunocore's last funding round was on Feb 2021 for a total of $258.3M
No recent investments found related to Immunocore